RAPT Therapeutics's total assets for Q3 2024 were $108.47M, a decrease of -14.72% from the previous quarter. RAPT total liabilities were $12.96M for the fiscal quarter, a -27.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.